Genentech Colon Cancer Drug Works with 2nd Chemo
498476
Genentech Inc.  on Monday said its  colon cancer drug Avastin extended the life of patients when  used in combination with a chemotherapy regimen called FOLFOX4  more than the chemotherapy alone in a late stage clinical  trial.
636079
New data presented today confirm that advanced lung cancer patients canlook forward to better-quality survival when treated with Alimta(R)(pemetrexed), a newly approved anticancer agent in the European Unioncompared with Taxotere(R) (docetaxel).
671952
THURSDAY, Jan. 27 (HealthDayNews) -- The results of a multi-center trial involving a quartet of drugs may bring fresh hope to patients battling advanced colorectal cancer, researchers reported Thursday.
753389
Adding the drug Avastin to a regimen of targeted therapy Erbitux and chemotherapy in patients with advanced colon cancer is more effective than the two drugs alone, a leading cancer researcher said on Wednesday.
350586
SAN FRANCISCO - A novel colon cancer-fighting drug developed by Genentech Inc. already on its way to blockbuster status got an additional boost Monday when the company announced Avastin helped some of the
122514
New data presented today has shown Xeloda, a targeted oral chemotherapy, improves disease outcomes and saves money when used as post surgery (adjuvant therapy) colon cancer treatment.
145479
Early-stage colon cancer patients treated with Eloxatin-based chemotherapy after their tumor had been removed by surgery survived longer than patients who had been on traditional chemotherapy care alone, French drugmaker Sanofi-Aventis said.
554933
Scientists reported promising gains Monday for treating colorectal cancer that has spread to the liver, showing that chemotherapy before and after surgery to remove liver tumors can help keep the disease in check.
632778
More than a quarter of patients with advanced kidney cancer saw their tumors shrink after treatment with GlaxoSmithKline Plc's pazopanib, a new pill designed to rival Genentech's blockbuster drug Avastin, researchers said on Saturday.
630746
Genentech Inc. and Swiss drug maker Roche Holding AG said Monday that a recent study showed their colon cancer drug Avastin significantly extended patient survival when combined with an oxaliplatin-based chemotherapy drug.
189115
LOS ANGELES/NEW YORK  - The U.S. Food and Drug   Administration said on Wednesday it had approved Amgen Inc's   drug Vectibix for the treatment of advanced colon cancer.
154392
A drug that helps the immune system attack lung cancer cells may improve survival time.
531441
GlaxoSmithKline Plc announced further clinical trial results on Sunday underlining the ability of a drug combination including its product Tykerb to fight breast cancer that has spread to the brain.
297310
U.S. regulators have approved wider use of Genentech Inc. and Biogen Idec Inc.'s drug Rituxan for patients with a type of lymphoma, the companies announced on Friday.
483706
NeoPharm Inc., a biotechnology company developing cancer treatments, said it regained ownership of two cancer compounds after Pfizer Inc.
688355
Genentech Inc.  said on Wednesday that second-quarter profit rose 41 percent, fueled by growth from cancer drugs Rituxan and Avastin.
161433
The U.S. Food and Drug   Administration said on Wednesday it had approved Amgen Inc's   drug Vectibix for the treatment of advanced colon cancer.